Delivery Order SPE2D021DA002-SPE2D326F2444
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,279.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector sets. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,045.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price procurement with no set-aside designation, demonstrating the company's competitive capability in unrestricted federal contracting. The delivery...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $3,833.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, was made without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order, valued at $2,590.25, was awarded on November 26, 2025, with completion scheduled for November 28, 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of epinephrine 0.3 mg auto-injector pens (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order carries a firm...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,045.50. Issued on December 1, 2025, with an ultimate completion date of December 2, 2025, this firm fixed-price delivery order represents a routine procurement under the company's existing pharmaceutical supply contract....
- The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a firm fixed-price delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is expected to be completed by September 5, 2025, and represents performance at the vendor's Park...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector (2 units). The award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. Performance will be executed in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for Epinephrine 0.3 mg auto-injector units (2-pack configuration) with a ceiling value of $1,394.00. The award, issued on July 23, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. This delivery order was issued without set-aside designation and is being fulfilled at the contractor's facility in...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F2444Delivery Order
The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,613.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract was awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and extends through December 31, 2036. DMS Pharmaceutical Group has established itself as a critical supplier within the Department of Defense's global pharmaceutical supply chain, leveraging its small business status to compete effectively while maintaining consistent performance across diverse product categories. The company's PPV-G GEN V contract authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for an extensive range of pharmaceutical products and medical consumables to support military healthcare facilities worldwide. The current delivery order for epinephrine auto-injectors exemplifies the emergency medication capabilities that DMS Pharmaceutical Group provides as part of its comprehensive portfolio supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/11/25 |